Cyteir Therapeutics

Kevin Mills, PhD

Co-founder and Chief Scientific Officer

Dr. Mills previously held appointments as Associate Professor of Genetics at the Jackson Laboratory, and Associate Director for Translational Partnerships in the Jackson Laboratory Cancer Center. Dr. Mills is an expert in genomic instability and mouse cancer modeling, with more than 30 published articles. Dr. Mills received his PhD from the Massachusetts Institute of Technology and did postdoctoral research at Harvard Medical School.